Saving money is wise, but investing is profitable
Email:
info@htif.ai
Phone:
+420558889755
Lang:
en
English
Русский
Czech
HTIF - High Tech Investment Finance
In accordance with the legislation of the Czech Republic, the Company provides services only to qualified investors!

AlloVir, Inc. (ALVR) gets the FDA clearance.

17.09.2020

AlloVir, Inc. announces the FDA clearance on investigation of new drug ALVR109 for the treatment of COVID-19. It is an allogeneic, off-the-shelf virus-specific T cell therapy candidate designed to target SARS-CoV-2 for high-risk COVID-19 patients. Proof-of-concept clinical trial with ALVR109 is planed to begin in the fourth quarter of 2020.